Author name: Leonardo Arias

FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More

George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest rejection reportedly driven by FDA’s top cancer regulator Richard Pazdur; Merck’s $3 billion savings push claims 6,000 jobs; and Pfizer CEO Albert Bourla addresses President Donald Trump’s new threats around Most Favored Nation drug pricing.

FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More Read More »

Scroll to Top